EU antitrust regulators resume Mars, Kellanova probe, decision due December 19

EU antitrust regulators have resumed their investigation into Mars' $36 billion acquisition of Kellanova, setting a December 19 deadline for a decision. The European Commission, which had temporarily paused its probe, is concerned the merger could lead to price increases and enhance Mars' negotiating leverage with retailers, despite the deal already receiving unconditional clearance in the United States.

Analysis

The European Commission has resumed its in-depth antitrust investigation into Mars' $36 billion acquisition of Kellanova, establishing a new decision deadline of December 19. This action prolongs the period of regulatory uncertainty for the deal, which had been on hold since late July. The Commission's probe is focused on material concerns that the merger could reduce competition, leading to consumer price increases and granting the combined entity excessive negotiating power over retailers. This significant regulatory hurdle in the EU, reflected by a moderately negative sentiment score (-0.5) for Kellanova (K), stands in stark contrast to the unconditional approval the deal has already received from U.S. authorities, highlighting a key jurisdictional risk to the transaction's closure.

Key Decisions for Investors

• Investors should recognize that the resumption of the EU probe introduces significant uncertainty and a key catalyst date of December 19, likely suppressing Kellanova's (K) stock price below the full acquisition value until a decision is reached.
• Merger arbitrageurs should anticipate increased volatility and a wider deal spread, as the risk of the transaction being blocked or requiring significant divestitures has materially increased.
• Shareholders of Kellanova should evaluate the company's standalone valuation, as a negative outcome from the EU review could cause the deal to fail, exposing the stock to downside risk based on its fundamental performance absent the acquisition premium.